- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type in United Kingdom
Total 4117 results
-
University of Michigan Rogel Cancer CenterBristol-Myers SquibbCompletedPeripheral T Cell LymphomaUnited States
-
Huda SalmaniCell Gene TherapeuticsRecruiting
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical CenterTerminated
-
Acrotech Biopharma Inc.Axis Clinicals LimitedCompletedPeripheral T-Cell Lymphoma (PTCL)United States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
TetraLogic PharmaceuticalsPPD; The Leukemia and Lymphoma Society; Veristat, Inc.; Therapeutics, Inc.CompletedLymphoma, T-Cell, CutaneousUnited States
-
Seagen Inc.Millennium Pharmaceuticals, Inc.CompletedLymphoma, Large-Cell, Anaplastic | Lymphoma, NK-cell | Lymphoma, T-cellUnited States, United Kingdom
-
University of DundeeCompletedBasal Cell Carcinoma | Bowen's DiseaseUnited Kingdom
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Seagen Inc.WithdrawnBrentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell LymphomaRecurrent Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-Cell Lymphoma | Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified | Recurrent Enteropathy-Associated T-Cell Lymphoma | Recurrent Follicular T-Cell Lymphoma | Recurrent Hepatosplenic T-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Jiangsu Simcere Pharmaceutical Co., Ltd.RecruitingAdvanced Solid Tumor | Cutaneous T-cell Lymphoma (CTCL)United States
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedPeripheral T-Cell LymphomaUnited States
-
Michelson Diagnostics Ltd.Skin Care Network Ltd.Terminated
-
NHS TaysideCompletedCarcinoma, Basal CellUnited Kingdom
-
Yale UniversityCompleted
-
National Cancer Institute (NCI)CompletedSubcutaneous Panniculitis-Like T-Cell Lymphoma | T-Cell Peripheral Lymphoma | Gamma Delta Hepatosplenic T-Cell Lymphoma | NK T-Cell LymphomaUnited States
-
Eli Lilly and CompanyCompletedCutaneous T-Cell LymphomaUnited States
-
Istituto Clinico HumanitasRecruitingSquamous Cell Carcinoma | Nasal Vestibule Carcinoma | Rhinectomy | Nasal VestibuleItaly, United Kingdom, France
-
Innate PharmaCompletedPeripheral T Cell LymphomaKorea, Republic of, United States
-
Nevada Cancer InstituteCLL TopicsTerminatedB Cell Lymphoma | T Cell LymphomaUnited States
-
Kyowa Kirin, Inc.CompletedCutaneous T-Cell LymphomaUnited States, Spain, France, Australia, Switzerland, United Kingdom, Japan, Denmark, Germany, Italy, Netherlands
-
University of MiamiNational Cancer Institute (NCI)TerminatedLymphoma | Precancerous/Nonmalignant ConditionUnited States
-
Great Ormond Street Hospital for Children NHS Foundation...Medical Research Council; UCL Great Ormond Street Institute of Child HealthRecruitingRelapsed/Refractory T-cell Acute Lymphoid LeukaemiaUnited Kingdom
-
Associazione Angela Serra per la ricerca sul cancroRecruitingPeripheral T-Cell LymphomaUnited States, Italy, Romania, Ukraine
-
National Cancer Institute (NCI)TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone Lymphoma | Waldenström Macroglobulinemia | Angioimmunoblastic T-cell Lymphoma and other conditionsUnited States
-
Boston UniversityLigand PharmaceuticalsCompletedCutaneous T-Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMycosis Fungoides | Recurrent Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-Cell Lymphoma | Refractory Anaplastic Large Cell Lymphoma | Recurrent Anaplastic Large Cell Lymphoma | Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified | Recurrent Enteropathy-Associated... and other conditionsUnited States
-
SoligenixCompletedCutaneous T-Cell Lymphoma/Mycosis FungoidesUnited States
-
University of Alabama at BirminghamSeagen Inc.; Kyowa Kirin, Inc.RecruitingMycosis Fungoides | Cutaneous T Cell LymphomaUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)RecruitingNon Hodgkin Lymphoma | Relapsed T-Cell Lymphoma | Refractory T-Cell LymphomaUnited States
-
Stanford UniversityTerminatedCutaneous T-cell Lymphoma | Cutaneous LymphomaUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationCompletedPreviously Untreated Peripheral T-cell LymphomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingAngioimmunoblastic T-cell Lymphoma | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Enteropathy-Associated T-Cell Lymphoma | Peripheral T-Cell Lymphoma, Not Otherwise Specified | Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma | Follicular T-Cell Lymphoma | Nodal Peripheral T-Cell Lymphoma...United States
-
Acrotech Biopharma Inc.CompletedCutaneous T-cell LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma | Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Cutaneous T-Cell Non-Hodgkin LymphomaUnited States
-
SethiMerck Sharp & Dohme LLCRecruitingT-Cell LymphomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
Eisai Inc.National Cancer Institute (NCI); Tufts Medical Center; Ligand PharmaceuticalsCompleted
-
National Cancer Institute (NCI)TerminatedRecurrent Cutaneous T-cell Non-Hodgkin Lymphoma | Stage I Cutaneous T-cell Non-Hodgkin Lymphoma | Stage II Cutaneous T-cell Non-Hodgkin LymphomaUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...RecruitingT-cell Acute Lymphoblastic Leukemia | T-cell Acute Lymphoblastic Lymphoma | T-non-Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma and other conditionsUnited States
-
Bausch Health Americas, Inc.CompletedRefractory Cutaneous T-cell LymphomaUnited States
-
Washington University School of MedicineCompletedLeukemia-Lymphoma, Adult T-CellUnited States
-
M.D. Anderson Cancer CenterOrtho Biotech, Inc.Completed
-
Northwestern UniversityCompleted
-
University of NebraskaNational Cancer Institute (NCI)CompletedAnaplastic Large Cell Lymphoma, ALK-Positive | Hepatosplenic T-Cell Lymphoma | Peripheral T-Cell Lymphoma, Not Otherwise Specified | Anaplastic Large Cell Lymphoma, ALK-Negative | Stage II Angioimmunoblastic T-cell Lymphoma | Stage II Enteropathy-Associated T-Cell Lymphoma | Stage III Angioimmunoblastic... and other conditionsUnited States
-
Tessa TherapeuticsActive, not recruitingAnaplastic Large Cell Lymphoma | Diffuse Large B Cell Lymphoma | Peripheral T Cell Lymphoma | Extranodal NK/T-cell Lymphoma | Primary Mediastinal Large B-Cell Lymphoma (PMBCL)United States
-
Kyowa Kirin, Inc.RecruitingCutaneous T Cell Lymphoma | ATLL | Leukemia/LymphomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
SCRI Development Innovations, LLCInfinity Pharmaceuticals, Inc.CompletedStudy of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic MalignanciesLymphoma | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | T-cell LymphomaUnited States
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCCompletedHodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Peripheral T-Cell LymphomaUnited States